Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arend

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Clinical Pharmacokinetics|October 11, 2021
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic StudyDirk Jan A R Moes, David J van Westerloo, Sandra M Arend, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 21, 2018
A novel view on the pathogenesis of complications after intravesical BCG for bladder cancerManu P Bilsen, Krista E van Meijgaarden, Hanna K de Jong, et al.
Infection and Immunity|September 10, 2009
Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteriaMay Young Lin, T B K Reddy, Sandra M Arend, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2006
Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contactsSandra M Arend, Steven F T Thijsen, Eliane M S Leyten, et al.
The European Respiratory Journal|January 21, 2022
Biomarkers to identify <i>Mycobacterium tuberculosis</i> infection among borderline QuantiFERON resultsJonathan W Uzorka, Jaap A Bakker, Krista E van Meijgaarden, et al.
EMBO Molecular Medicine|July 7, 2021
High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversionPhilipp E Geyer, Florian M Arend, Sophia Doll, et al.
Clinical Kidney Journal|October 4, 2021
Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patientsMichael Paal, Florian M Arend, Tobias Lau, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Microbes and Infection|August 26, 2006
Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosisEliane M S Leyten, May Young Lin, Kees L M C Franken, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Clinical Pharmacokinetics|October 11, 2021
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic StudyDirk Jan A R Moes, David J van Westerloo, Sandra M Arend, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 21, 2018
A novel view on the pathogenesis of complications after intravesical BCG for bladder cancerManu P Bilsen, Krista E van Meijgaarden, Hanna K de Jong, et al.
Infection and Immunity|September 10, 2009
Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteriaMay Young Lin, T B K Reddy, Sandra M Arend, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2006
Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contactsSandra M Arend, Steven F T Thijsen, Eliane M S Leyten, et al.
The European Respiratory Journal|January 21, 2022
Biomarkers to identify <i>Mycobacterium tuberculosis</i> infection among borderline QuantiFERON resultsJonathan W Uzorka, Jaap A Bakker, Krista E van Meijgaarden, et al.
EMBO Molecular Medicine|July 7, 2021
High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversionPhilipp E Geyer, Florian M Arend, Sophia Doll, et al.
Clinical Kidney Journal|October 4, 2021
Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patientsMichael Paal, Florian M Arend, Tobias Lau, et al.
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Microbes and Infection|August 26, 2006
Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosisEliane M S Leyten, May Young Lin, Kees L M C Franken, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
Pageof 15